Abstract:Enantioselective hydrogenation of beta-amino ketones is a powerful tool to produce bioactive molecules, but their asymmetric transformation is synthetically challenging. Here, an iridium-catalysed system with tridentate ferrocene-based phosphine ligands bearing unsymmetrical vicinal diamine scaffolds is developed for the efficient asymmetric synthesis of diverse gamma tertiary-amino and gamma-secondary-amino alcohols, including intermediates of (S)-duloxetine, (R)-fluoxetine and (R)-atomoxetine. Chiral gamma-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of beta-amino ketones provides a straightforward and powerful tool for the synthesis of chiral gamma-amino alcohols, but the asymmetric transformation is synthetically challenging. Here, a series of tridentate ferrocene-based phosphine ligands bearing modular and tunable unsymmetrical vicinal diamine scaffolds were designed, synthesized, and evaluated in the iridium-catalyzed asymmetric hydrogenation of beta-amino ketones. The system was greatly effective to substrates with flexible structure and functionality, and diverse beta-tertiary-amino ketones and beta-secondary-amino ketones were hydrogenated smoothly. The excellent reactivities and enantioselectivities were achieved in the asymmetric delivery of various chiral gamma-amino alcohols with up to 99% yields, >99% ee values, and turnover number (TON) of 48,500. The gram-scale reactions with low catalyst loading showed the potential application in industrial synthesis of chiral drugs, such as (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine.

Research progresses in chemoenzymatic synthesis of Duloxetine hydrochloride

Study on the Industryial Production of Citalopram

Synthesis of Antidepressant Drug Duloxetine Hydrochloride

Chemo-enzymatic Asymmetric Synthesis of S-citalopram by Lipase-Catalyzed Cyclic Resolution and Stereoinversion of Quaternary Stereogenic Center.

Iridium-catalyzed enantioselective synthesis of chiral -amino alcohols and intermediates of (<i>S</i>)-duloxetine, (<i>R</i>)-fluoxetine, and (<i>R</i>)-atomoxetine

Enantioselective Transformations in the Synthesis of Therapeutic Agents

Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of ( S )-duloxetine, ( R )-fluoxetine, and ( R )-atomoxetine

Discovery and utilization of biocatalysts for chiral synthesis: an overview of Chinese scientists' research and development.

Asymmetric Transfer Hydrogenation ofβ-Amino Ketone Catalyzed by (S,S)-TsDPEN-Ru Complex and Its Application in the Synthesis of Duloxetine

Synthesizing Chiral Drug Intermediates by Biocatalysis

Chirality of antidepressive drugs: an overview of stereoselectivity

Synthesis of Duloxetine Hydrochloride

An Access to Chiral Phthalides: Enantioselective Synthesis of Escitalopram

Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review

New opportunities for biocatalysis: driving the synthesis of chiral chemicals.

A Novel and Practical Asymmetric Synthesis of Dapoxetine Hydrochloride

Graphical synthetic routes of Escitalopram

Development of an Efficient and Scalable Biocatalytic Route to (1S,4r)-8-hydroxy-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl Propionate Via Enantioselective Enzymatic Desymmetrization of a Prochiral Diester

Enantio‐ and Diastereoselective Synthesis of Chiral Syn ‐Aryl β‐Hydroxy α‐Amino Esters via Biocatalytic Dynamic Reductive Kinetic Resolution

Efficient Biocatalytic Synthesis of Chiral Chemicals.

Recent advances in the chemoenzymatic synthesis of bioactive natural products